Arbro Pharmaceuticals partnered with Jamia Hamdard to carry out research to develop a novel formulation which can overcome curcumin\'s poor bioavailability. The development project was jointly funded by Arbro and the Department of Science and Technology Government of India under its DPRP scheme.
New Delhi : Arbro Pharmaceuticals has launched SNEC30, a patented
highly bioavailable Self Nano Emulsifying Curcumin formulation in 30
Curcumin is the active ingredient
of turmeric/Haldi which has
been widely used in traditional
medicine and home remedies in
India for hundreds of years.
Clinical research conducted over
the last 25 years has shown
curcumin to be effective in
various diseases like cancer,
pain, inflammation, arthritis,
ulcers, psoriasis, arteriosclerosis,
diabetes and many more pro-inflammatory conditions.
Despite of its effectiveness against so many conditions, scientists have
?elie?ed that ?ur?u?i?’s true pote?tial has ?ee? li?ited ?y its poor
bioavailability which is caused by its poor solubility and extensive pre-
Arbro Pharmaceuticals partnered with Jamia Hamdard to carry out
research to develop a novel formulation which can overcome
?ur?u?i?’s poor ?ioa?aila?ility. The de?elop?e?t proje?t ?as jointly
funded by Arbro and the Department of Science and Technology
Government of India under its DPRP scheme.
SNEC30 is the outcome of this joint development and is based on a
novel self nano emulsifying drug delivery system for which patents have
been filed and the US patent has been granted.
potential of curcumin but its poor bioavailability was a
limiting factor, our research group together with Arbro
took the challenge and applied nanotechnology to
overcome this limitation and achieve highest ever
?ioavaila?ility for ?ur?u?i?? said Dr. Kanchan Kohli,
Asst. Prof Faculty of Pharmacy, Jamia Hamdard who is
one of the main inventors of the technology.
?Just 30 ?g of ?ur?u?i? i? o?e ?apsule of “NEC30 has
shown higher blood levels than what can be achieved by
consuming the curcumin content of 1 kg of raw
haldi/tur?eri?? said Mr. Vijay Kumar Arora, Managing
Director, Arbro Pharmaceuticals.
Arbro pharmaceuticals is a 30-year-old research oriented company with
its own research and development, testing and manufacturing facilities.
Arbro has been manufacturing and exporting more than hundred
formulations under its own brand name to more than 10 countries.